Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatrics | 5 | 2020 | 68 | 1.870 |
Why?
|
| Internship and Residency | 5 | 2020 | 125 | 1.730 |
Why?
|
| Rheumatic Fever | 4 | 2016 | 13 | 1.120 |
Why?
|
| Streptococcal Infections | 3 | 2020 | 34 | 0.850 |
Why?
|
| Physicians | 3 | 2020 | 163 | 0.740 |
Why?
|
| Glomerulonephritis | 1 | 2020 | 13 | 0.730 |
Why?
|
| Schools, Medical | 3 | 2020 | 198 | 0.670 |
Why?
|
| Length of Stay | 1 | 2020 | 185 | 0.670 |
Why?
|
| Cardiac Myosins | 2 | 2016 | 8 | 0.660 |
Why?
|
| Professional Practice Location | 2 | 2020 | 15 | 0.660 |
Why?
|
| Thoracic Wall | 1 | 2017 | 1 | 0.620 |
Why?
|
| Joint Instability | 1 | 2017 | 4 | 0.620 |
Why?
|
| Chest Pain | 1 | 2017 | 37 | 0.600 |
Why?
|
| Hawaii | 10 | 2020 | 1929 | 0.600 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 32 | 0.600 |
Why?
|
| Sex Factors | 1 | 2020 | 898 | 0.580 |
Why?
|
| Streptococcus pyogenes | 5 | 2020 | 27 | 0.580 |
Why?
|
| Autoantibodies | 2 | 2016 | 103 | 0.560 |
Why?
|
| Suction | 1 | 2014 | 3 | 0.490 |
Why?
|
| Ganglion Cysts | 1 | 2014 | 3 | 0.490 |
Why?
|
| Knee Joint | 1 | 2014 | 9 | 0.480 |
Why?
|
| Methotrexate | 1 | 2014 | 23 | 0.480 |
Why?
|
| Education, Medical | 1 | 2015 | 104 | 0.460 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2007 | 155 | 0.440 |
Why?
|
| Biomedical Research | 1 | 2012 | 400 | 0.300 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2007 | 13 | 0.290 |
Why?
|
| Rheumatology | 1 | 2007 | 16 | 0.290 |
Why?
|
| Humans | 21 | 2020 | 37093 | 0.280 |
Why?
|
| Referral and Consultation | 1 | 2007 | 117 | 0.270 |
Why?
|
| Child, Preschool | 5 | 2020 | 1418 | 0.250 |
Why?
|
| Child | 8 | 2020 | 3131 | 0.250 |
Why?
|
| History, 21st Century | 2 | 2015 | 81 | 0.240 |
Why?
|
| History, 20th Century | 2 | 2015 | 117 | 0.240 |
Why?
|
| Odds Ratio | 2 | 2020 | 534 | 0.220 |
Why?
|
| Poverty | 1 | 2006 | 348 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 628 | 0.210 |
Why?
|
| Adolescent | 6 | 2017 | 5363 | 0.210 |
Why?
|
| Myofascial Pain Syndromes | 1 | 2001 | 1 | 0.210 |
Why?
|
| Massage | 1 | 2001 | 8 | 0.200 |
Why?
|
| Treatment Outcome | 2 | 2017 | 1369 | 0.200 |
Why?
|
| Female | 8 | 2020 | 20969 | 0.200 |
Why?
|
| Health Planning | 1 | 2001 | 16 | 0.190 |
Why?
|
| Financing, Government | 1 | 2001 | 19 | 0.190 |
Why?
|
| Developing Countries | 1 | 2001 | 99 | 0.190 |
Why?
|
| Cultural Diversity | 1 | 2002 | 169 | 0.190 |
Why?
|
| Health Personnel | 2 | 2019 | 228 | 0.180 |
Why?
|
| Burnout, Professional | 1 | 2019 | 19 | 0.170 |
Why?
|
| Empathy | 1 | 2019 | 28 | 0.170 |
Why?
|
| Clergy | 1 | 2019 | 12 | 0.170 |
Why?
|
| Japan | 2 | 2015 | 305 | 0.170 |
Why?
|
| Terminal Care | 1 | 2019 | 45 | 0.160 |
Why?
|
| Pain | 1 | 2001 | 251 | 0.160 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 66 | 0.160 |
Why?
|
| Incidence | 2 | 2020 | 922 | 0.160 |
Why?
|
| Epitopes | 2 | 2016 | 148 | 0.160 |
Why?
|
| Hospitalization | 1 | 2020 | 388 | 0.140 |
Why?
|
| Pain Measurement | 1 | 2017 | 171 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 610 | 0.140 |
Why?
|
| Male | 7 | 2020 | 20025 | 0.140 |
Why?
|
| Faculty | 2 | 2019 | 94 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 448 | 0.130 |
Why?
|
| Acute Disease | 3 | 2007 | 147 | 0.130 |
Why?
|
| History, 17th Century | 1 | 2015 | 5 | 0.130 |
Why?
|
| History, 18th Century | 1 | 2015 | 6 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 974 | 0.130 |
Why?
|
| Arthralgia | 1 | 2014 | 11 | 0.120 |
Why?
|
| Range of Motion, Articular | 1 | 2014 | 31 | 0.120 |
Why?
|
| Antirheumatic Agents | 1 | 2014 | 31 | 0.120 |
Why?
|
| Career Choice | 1 | 2013 | 45 | 0.110 |
Why?
|
| Adult | 5 | 2020 | 11712 | 0.110 |
Why?
|
| Publications | 1 | 2012 | 7 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2016 | 1492 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 481 | 0.090 |
Why?
|
| Rheumatic Heart Disease | 1 | 2010 | 5 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 219 | 0.090 |
Why?
|
| Virulence Factors | 1 | 2010 | 113 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 187 | 0.080 |
Why?
|
| Penicillins | 1 | 2007 | 12 | 0.080 |
Why?
|
| Hospitals, Rural | 1 | 2007 | 21 | 0.070 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 39 | 0.070 |
Why?
|
| Urban Health | 1 | 2007 | 95 | 0.070 |
Why?
|
| Chorea | 1 | 2006 | 1 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 540 | 0.070 |
Why?
|
| Antibodies | 1 | 2006 | 141 | 0.070 |
Why?
|
| Prevalence | 2 | 2007 | 1455 | 0.060 |
Why?
|
| Rural Population | 1 | 2007 | 294 | 0.060 |
Why?
|
| Urine | 1 | 2003 | 13 | 0.060 |
Why?
|
| Lupus Nephritis | 1 | 2003 | 23 | 0.060 |
Why?
|
| Infant | 1 | 2007 | 1046 | 0.060 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2003 | 22 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 234 | 0.050 |
Why?
|
| Philippines | 1 | 2002 | 73 | 0.050 |
Why?
|
| Health Planning Support | 1 | 2001 | 2 | 0.050 |
Why?
|
| China | 1 | 2002 | 196 | 0.050 |
Why?
|
| Negotiating | 1 | 2001 | 25 | 0.050 |
Why?
|
| Micronesia | 1 | 2001 | 80 | 0.050 |
Why?
|
| Inservice Training | 1 | 2001 | 33 | 0.050 |
Why?
|
| Public Health Practice | 1 | 2001 | 40 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2001 | 56 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2003 | 253 | 0.050 |
Why?
|
| Myosins | 1 | 1999 | 36 | 0.040 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 1999 | 24 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 282 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2003 | 2026 | 0.040 |
Why?
|
| Health Resources | 1 | 2019 | 32 | 0.040 |
Why?
|
| Myocardium | 1 | 1999 | 235 | 0.040 |
Why?
|
| Depression | 2 | 2019 | 712 | 0.040 |
Why?
|
| Curriculum | 1 | 2019 | 265 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2006 | 1908 | 0.040 |
Why?
|
| Anxiety | 2 | 2019 | 754 | 0.040 |
Why?
|
| United States | 2 | 2007 | 4223 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 1568 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2010 | 31 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 59 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 32 | 0.020 |
Why?
|
| Pharynx | 1 | 2010 | 16 | 0.020 |
Why?
|
| Blood | 1 | 2010 | 37 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2010 | 186 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 149 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 237 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 306 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 623 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 474 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 997 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 689 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 626 | 0.020 |
Why?
|
| G(M2) Ganglioside | 1 | 2006 | 4 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 2006 | 7 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2006 | 16 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 352 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 2003 | 30 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2003 | 21 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2003 | 46 | 0.010 |
Why?
|
| Proteinuria | 1 | 2003 | 50 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 2003 | 61 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 159 | 0.010 |
Why?
|
| Aggression | 1 | 2003 | 89 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 661 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 923 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1999 | 3 | 0.010 |
Why?
|
| Myosin Subfragments | 1 | 1999 | 3 | 0.010 |
Why?
|
| Immune Sera | 1 | 1999 | 59 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1999 | 79 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2003 | 1067 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 404 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1999 | 308 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 859 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 1180 | 0.010 |
Why?
|
| Animals | 2 | 2006 | 15081 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2003 | 730 | 0.010 |
Why?
|
| Cell Line | 1 | 1999 | 1354 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 3562 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 3483 | 0.010 |
Why?
|